Trial reportOpen heart2026
Effect of pictorial-based information about atherosclerosis on adherence to lifestyle recommendations: results from the VIPVIZA randomised controlled trial.
Trial report in Open heart, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01849575 (Direct VIsualiZAtion of Asymptomatic Atherosclerotic Disease for Optimum Cardiovascular Prevention. A Population Based Pragmatic Randomised Controlled Trial Within Västerbotten Intervention Programme), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Direct VIsualiZAtion of Asymptomatic Atherosclerotic Disease for Optimum Cardiovascular Prevention. A Population Based Pragmatic Randomised Controlled Trial Within Västerbotten Intervention Programme (VIP) and Ordinary Care.
Who cites it
1 citing paper in PubMed.
- Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimLow adherence to a healthy lifestyle constitutes a major barrier to effective prevention of cardiovascular disease. We aimed to investigate the effect of pictorial-based information about subclinical atherosclerosis on adherence to health-promoting lifestyle recommendations.
methodsVisualization of Asymptomatic Atherosclerotic Disease for Optimum Cardiovascular Prevention (VIPVIZA) is a pragmatic, open-label randomised controlled trial within the Västerbotten Intervention Programme (VIP) in Sweden. In the VIP, residents of Västerbotten county are invited to a health survey and a health-promoting dialogue at the ages of 40, 50 and 60.A total of 3532 VIP participants were included in VIPVIZA during 2013-2016. They underwent a carotid ultrasound examination in addition to the usual VIP process and were randomised 1:1 to intervention group (receiving graphical colour-coded and age-related information about carotid intima-media thickness and plaques, written information about atherosclerosis and a motivational dialogue) or control group (no information or dialogue).We developed a lifestyle index based on self-reported physical activity, smoking habits, diet and alcohol consumption, ranging from 4 to 12, with higher levels indicating healthier lifestyles. We used ordinal regression to compare the lifestyle index in the intervention and control groups at the 3-year follow-up, with adjustments for baseline levels of lifestyle index, age, sex and education.
resultsThe OR for having a healthier lifestyle index after 3 years was 1.20 (95% CI 1.01 to 1.42, p=0.03), comparing the intervention group to the control group. We found no interactions for age, sex or education.
conclusionOur findings provide some evidence for the contributory role of pictorial-based information about subclinical atherosclerosis in promoting sustained healthy lifestyle habits. TRIAL REGISTRATION NUMBER: NCT01849575.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.